CFG
TXG icon

Citizens Financial Group’s 10x Genomics TXG Stock Holding History

Citizens Financial Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-4,296
Closed -$240K – 466
2023
Q1 		$240K Buy
+4,296
New +$201K 0.01% 404
2022
Q3 		– Sell
-5,818
Closed -$263K – 434
2022
Q2 		$263K Buy
5,818
+1,698
+41% +$88.1K 0.01% 366
2022
Q1 		$313K Buy
4,120
+994
+32% +$87K 0.01% 356
2021
Q4 		$466K Buy
+3,126
New +$479K 0.02% 298

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

Citizens Financial Group's TXG Position: Q2 2023 in Review

Citizens Financial Group sold out of 10x Genomics (TXG) in Q2 2023, closing a stake of 4,296 shares — an estimated $240K sold.

Citizens Financial Group first reported a position in TXG in Q4 2021 and held it in 4 quarters. The position peaked at $466K in Q4 2021. 274 funds tracked by Wall St. Rank hold TXG as of Q2 2023.

  • Citizens Financial Group reported no remaining 10x Genomics position as of Q2 2023 after selling out during the quarter.
  • Citizens Financial Group sold 4,296 10x Genomics shares in Q2 2023, an estimated $240K.
  • Citizens Financial Group first reported a position in 10x Genomics in Q4 2021 and held it in 4 quarters.
  • Citizens Financial Group's 10x Genomics position peaked at $466K in Q4 2021.
  • 274 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2023.

Based on Citizens Financial Group's 13F filing for Q2 2023, filed 4 Aug 2023.